BBA
Baker Bros. Advisors’s Intellia Therapeutics NTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.1M | Buy |
2,675,674
+2,031,558
| +315% | +$19.1M | 0.24% | 33 |
|
|
2025
Q1 | $4.58M | Hold |
644,116
| – | – | 0.05% | 60 |
|
|
2024
Q4 | $7.51M | Buy |
+644,116
| New | +$7.51M | 0.08% | 61 |
|
|
2021
Q1 | – | Sell |
-111,296
| Closed | -$6.06M | – | 129 |
|
|
2020
Q4 | $6.06M | Sell |
111,296
-10,942
| -9% | -$595K | 0.02% | 88 |
|
|
2020
Q3 | $2.43M | Sell |
122,238
-6,300
| -5% | -$125K | 0.01% | 99 |
|
|
2020
Q2 | $2.7M | Hold |
128,538
| – | – | 0.01% | 93 |
|
|
2020
Q1 | $1.57M | Hold |
128,538
| – | – | 0.01% | 95 |
|
|
2019
Q4 | $1.89M | Hold |
128,538
| – | – | 0.01% | 85 |
|
|
2019
Q3 | $1.72M | Hold |
128,538
| – | – | 0.01% | 88 |
|
|
2019
Q2 | $2.1M | Hold |
128,538
| – | – | 0.01% | 85 |
|
|
2019
Q1 | $2.2M | Hold |
128,538
| – | – | 0.01% | 78 |
|
|
2018
Q4 | $1.76M | Sell |
128,538
-64,000
| -33% | -$874K | 0.01% | 76 |
|
|
2018
Q3 | $5.51M | Sell |
192,538
-354,384
| -65% | -$10.1M | 0.04% | 69 |
|
|
2018
Q2 | $15M | Sell |
546,922
-286,873
| -34% | -$7.85M | 0.11% | 50 |
|
|
2018
Q1 | $17.6M | Sell |
833,795
-311,658
| -27% | -$6.57M | 0.15% | 44 |
|
|
2017
Q4 | $22M | Buy |
1,145,453
+83,333
| +8% | +$1.6M | 0.19% | 43 |
|
|
2017
Q3 | $26.4M | Hold |
1,062,120
| – | – | 0.21% | 32 |
|
|
2017
Q2 | $17M | Hold |
1,062,120
| – | – | 0.15% | 36 |
|
|
2017
Q1 | $15M | Hold |
1,062,120
| – | – | 0.12% | 37 |
|
|
2016
Q4 | $13.9M | Hold |
1,062,120
| – | – | 0.14% | 40 |
|
|
2016
Q3 | $18.1M | Hold |
1,062,120
| – | – | 0.16% | 37 |
|
|
2016
Q2 | $22.7M | Buy |
+1,062,120
| New | +$22.7M | 0.24% | 31 |
|